Daniel's practice focuses on M&A transactions and corporate law.

He advises listed companies, family businesses and private equity clients on private and public takeovers as well as corporate matters and reorganisations. His practice includes auction processes, dual track deals, carve outs, joint ventures, as well as co-investments including management participations.

Daniel was recently involved, among other matters, in advising

  • Trill Impact on the acquisition of majority participations in Meona Group and i-SOLUTIONS,
  • PAI Partners on the acquisition of Apleona,
  • Deutsche Börse on the acquisition of ISS as well as the acquisition of Axioma and the strategic partnership with General Atlantic in connection with the creation of a new index and portfolio / risk analytics provider,
  • Siemens on the sale of Flender to Carlyle,
  • EQT on the acquisition of a participation in SHL Medical and the sale of CBR Group,
  • Knorr Bremse on the acquisition of R.H. Sheppard,
  • Hymer on the sale to Thor Industries,
  • family shareholders of Renolit SE and RKW SE in connection with the demerger of the group amongst their shareholders,
  • Bain Capital on the disposal of a participation in Wittur Group,
  • Otto Group on EOS' sale of Health AG and Zahnärztekasse AG,
  • HENSOLDT on the acquisition of EuroAvionics,
  • Lone Star on the acquisition of Xella,
  • METRO / real on a joint venture,
  • Pfeiffer Vacuum on the takeover offer by Busch, as well as
  • Waterland in connection with the acquisition of Median clinics and further clinic transactions.


  • Admitted to bar 2011
  • Attorney-at-Law (New York)
  • Universities of Münster and Heidelberg (Dr. iur.)
  • New York University (LL.M.)
  • Hengeler Mueller London, 2015-2016


  • Haftung des Managements und Drittschutz, 2011
  • Empty Voting als moderner Stimmenkauf?, NZG 2010, 607-611 (together with Ingo Theusinger)
  • Eigenkapitalderivate, wirtschaftliches Eigentum und verdeckte Stimmmacht, ZVglRWiss 109, 2010, 94-131